Insperity, Inc.
Insperity, Inc. Q3 FY2026 earnings call
October 29, 2026 · fiscal period ended 2026-09
EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2026-10-29
Management highlights
- Margin Recovery Success: The cumulative impact of pricing strategies and client retention efforts has successfully reversed previous declines, validating the effectiveness of the margin recovery plan initiated in early 2026.
- Sales and Retention Strategy: While new sales and retention faced headwinds due to strict client selection, activity metrics (business profiles/opportunities to bid) trended upward in Q3. The fall sales campaign is underway with improved marketing lead flow and a solid pipeline of mid-market prospects.
- Product Segment Progress: HR Scale remains on track to meet targets with several thousand employees in implementation. HR 360 is gaining traction among mid-market clients seeking faster onboarding, with many viewing it as a stepping stone to HR Scale, indicating long-term relationship potential.
- AI Strategic Initiative: Insperity is leveraging AI to enhance service delivery and client value through three pillars: developing technology/services more productively, equipping internal staff with better tools via a proprietary platform, and enhancing client experience with the 'HR 360 AI Agent'.
- Market Context: Management acknowledges ongoing challenges including price sensitivity, market uncertainty, and elevated healthcare trends, but believes AI-driven workplace transformation will increase demand for comprehensive HR solutions among SMBs.
Segment performance
Insperity reported strong financial improvements in Q3 2026, marking a key milestone in its margin recovery plan. Total gross profit increased by 6% year-over-year to $207 million, with gross profit per worksite employee rising 8% to $225 per month. Adjusted EBITDA surged 210% to $31 million, reversing the losses seen in Q3 2025. The company’s paid worksite employees averaged 307,265 for the quarter, reflecting a modest 1.8% decline as the firm prioritized profitability over volume growth. Operating expenses decreased by 5% to $209 million, driven by lower corporate staffing levels and compensation costs. Benefits cost per covered employee increased by 3.7%, consistent with expectations, while workers' compensation costs saw a year-over-year increase due to favorable actuarial reserve adjustments declining compared to the prior year.
Guidance
- Q4 2026 Paid Worksite Employees: Forecasted between 306,000 and 308,000, representing a 1.4% to 2.0% decrease from Q4 2025. Sequential growth is expected to be relatively flat as new hires offset attrition.
- Full Year 2026 Paid Worksite Employees: Forecasted between 305,500 and 306,000, a 1.3% to 1.5% decrease from 2025.
- Q4 2026 Adjusted EBITDA: Forecasted in a range of $24 million to $44 million, compared to negative $13 million in Q4 2024.
- Full Year 2026 Adjusted EBITDA: Forecasted between $194 million and $214 million, an increase of 48% to 63% over 2025.
- Full Year 2026 Adjusted EPS: Forecasted between $1.93 and $2.28 per share, an increase of 87% to 121% over 2025.
- Q4 2026 Adjusted EPS: Forecasted between 7 cents and 42 cents per share, compared to a loss of 60 cents in Q4 2025.
Risks
- Workers' Compensation Costs: Market-wide increases in claim severity and elevated healthcare cost trends are impacting workers' compensation reserves, leading to higher reported costs despite stability in current period claims.
- Client Attrition and Sales Headwinds: The margin recovery plan’s strict pricing and client selection criteria have negatively impacted new client sales and retention volumes, creating a trade-off between profitability and growth.
- Healthcare Cost Trends: Although managed effectively this year through structural changes, underlying health insurance cost trends remain high and could pressure margins if not actively managed.
- Market Uncertainty: Ongoing economic uncertainty and political factors may influence client behavior and sales conversion rates during the critical year-end transition period.
Q&A highlights
Q: Analyst asked about the balance between Insperity's proprietary AI development and leveraging Workday's AI capabilities, and future healthcare cost trends.
A: Paul Sarvadi stated that while Workday offers valuable AI possibilities, Insperity relies heavily on its own extensive data, historical client information, and expert workforce to deliver tailored solutions. Regarding costs, Jim Allison noted that benefits cost trends are currently under market rate due to structural plan changes and pricing strategies, which should provide a tailwind this year but become neutral next year. He also highlighted that workers' comp markets are hardening, requiring vigilant pricing actions.
Q: Analyst inquired about the progress of the joint go-to-market strategy with Workday for HR Scale and whether HR Scale will be a material growth driver for EBITDA.
A: Paul Sarvadi confirmed that the pipeline is building with several thousand employees in the queue for implementation, keeping them on track. He emphasized that offering both HR 360 and HR Scale allows mid-market clients to start with a faster onboarding option (360) while committing to HR Scale as their long-term solution. He expects HR Scale to be a significant component of mid-market growth and EBITDA improvement.
Q: Analyst asked for details on the timeline for clients transitioning from HR 360 to HR Scale and how OpEx/compensation might change as sales recover.
A: Paul Sarvadi explained that AI-driven workplace transformation is increasing the need for sophisticated HR functions, making the transition to deeper services like HR Scale timely. On OpEx, Jim Allison noted that headcount was right-sized earlier in the year, yielding current savings. However, as sales activity and growth reemerge, they plan to reinvest in compensation and operations, though specific plans for next year remain agile due to year-end churn and uncertainty.
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | $0.22 | $0.21 | +3.0% | — |
| Revenue | $1.65B | $1.64B | +0.9% | — |
Transcript
October 29, 2026Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.